Filing Details

Accession Number:
0001209191-14-012496
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-20 17:17:13
Reporting Period:
2014-02-18
Filing Date:
2014-02-20
Accepted Time:
2014-02-20 17:17:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
768408 Cyanotech Corp CYAN Medicinal Chemicals & Botanical Products (2833) 911206026
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201156 / A Michael Davis 73-4460 Queen Kaahumanu Hwy #102
Kailua-Kona HI 96740
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-02-18 30,769 $0.00 100,000 No 4 G Indirect By self as director of Skywords Family Foundation Inc.
Common Stock Acquisiton 2014-02-19 50,000 $5.34 423,213 No 4 P Indirect By self as trustee of the Michael Arlen Davis Revocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 G Indirect By self as director of Skywords Family Foundation Inc.
No 4 P Indirect By self as trustee of the Michael Arlen Davis Revocable Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,750 Direct
Common Stock 350,000 Indirect By self as co-trustee of the Michael Arlen Davis Charitable Lead Annuity Trust
Common Stock 31,250 Indirect By spouse
Common Stock 150,000 Indirect By self as co-trustee for trusts for the benefit of Mr. Davis's children
Common Stock 25,000 Indirect By self as UTMA custodian for daughter
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.09 to $5.40, inclusive. The reporting person undertakes to provide to Cyanotech Corporation, any security holder of Cyanotech Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. Includes 42,313 shares previously owned directly, and 750 shares previously owned indirectly as co-trustee of the Michael Davis 1993 Family Trust, which were contributed to the Michael Arlen Davis Revocable Trust on December 20, 2013 and December 17, 2013, respectively.
  3. Includes 50 shares that were erroneously omitted from previous reports.